4.6 Article

Effects of Label Noise on Deep Learning-Based Skin Cancer Classification

Journal

FRONTIERS IN MEDICINE
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2020.00177

Keywords

dermatology; artificial intelligence; label noise; skin cancer; melanoma; nevi

Funding

  1. Federal Ministry of Health, Berlin, Germany

Ask authors/readers for more resources

Recent studies have shown that deep learning is capable of classifying dermatoscopic images at least as well as dermatologists. However, many studies in skin cancer classification utilize non-biopsy-verified training images. This imperfect ground truth introduces a systematic error, but the effects on classifier performance are currently unknown. Here, we systematically examine the effects of label noise by training and evaluating convolutional neural networks (CNN) with 804 images of melanoma and nevi labeled either by dermatologists or by biopsy. The CNNs are evaluated on a test set of 384 images by means of 4-fold cross validation comparing the outputs with either the corresponding dermatological or the biopsy-verified diagnosis. With identical ground truths of training and test labels, high accuracies with 75.03% (95% CI: 74.39-75.66%) for dermatological and 73.80% (95% CI: 73.10-74.51%) for biopsy-verified labels can be achieved. However, if the CNN is trained and tested with different ground truths, accuracy drops significantly to 64.53% (95% CI: 63.12-65.94%, p < 0.01) on a non-biopsy-verified and to 64.24% (95% CI: 62.66-65.83%, p < 0.01) on a biopsy-verified test set. In conclusion, deep learning methods for skin cancer classification are highly sensitive to label noise and future work should use biopsy-verified training images to mitigate this problem.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer

Max Jung, Michael Rose, Ruth Knuechel, Chiara Loeffler, Hannah Muti, Jakob Nikolas Kather, Nadine T. Gaisa

Summary: Quantitative analysis of immune phenotypes in squamous bladder cancer (sq-BLCA) revealed that hot tumor-immune phenotypes with high PD-L1 expression might be a promising strategy for ICI therapy in sq-BLCA.

BMC CANCER (2023)

Article Oncology

Characterisation and outcome of RAC1 mutated melanoma

Georg C. Lodde, Philipp Jansen, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pfoehler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Antje Sucker, Jan-Malte Placke, Anne Zaremba, Lea Jessica Albrecht, Bernd Kowall, Wolfgang Galetzka, Jürgen C. Becker, Alpaslan Tasdogan, Lisa Zimmer, Elisabeth Livingstone, Eva Hadaschik, Dirk Schadendorf, Selma Ugurel, Klaus Griewank

Summary: RAC1 mutations are rare in melanoma, mostly originating from the skin or of unknown origin, and often coexist with MAP kinase mutations. Immune checkpoint inhibitors have shown to be effective in treating advanced disease.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website-A Mixed-methods Approach

Theresa Steeb, Julia Bruetting, Lydia Reinhardt, Julia Hoffmann, Nina Weiler, Markus Heppt, Michael Erdmann, Astrid Doppler, Christiane Weber, Dirk Schadendorf, Friedegund Meier, Carola Berking

Summary: Skin cancer patients are increasingly using the internet to find information about their disease. However, online information can be misleading. SKINFO is a new website designed specifically for German-speaking skin cancer patients, providing reliable and verified information. Usability testing of the website showed that while patients appreciated the content and design, improvements could be made in terms of navigation and providing more specific information for patients' relatives.

JOURNAL OF CANCER EDUCATION (2023)

Article Dermatology

Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases

Dana Westphal, Matthias Meinhardt, Konrad Gruetzmann, Lisa Schoene, Julian Steininger, Lena T. Neuhaus, Miriam Wiegel, Daniel Schrimpf, Daniela E. Aust, Evelin Schroeck, Gustavo B. Baretton, Stefan Beissert, Tareq A. Juratli, Gabriele G. Schackert, Jan Gravemeyer, Juergen C. Becker, Andreas von Deimling, Christian Koelsche, Barbara Klink, Friedegund Meier, Alexander Schulz, Michael H. Muders, Michael Seifert

Summary: This study integrated omics data analysis to evaluate the methylomes and transcriptomes of matched melanoma metastases, identifying 38 candidate genes with distinct promoter methylation and gene expression changes in intracranial compared with extracranial metastases. The protein expression of the 11 most promising genes was validated using immunohistochemistry, and significant differences were observed in intracranial metastases. Knockdown of PRKCZ or GRB10 altered protein kinase B expression and decreased the viability of a brain-specific melanoma cell line. These findings provide insights into the molecular mechanisms that differentiate brain metastases and could be targeted for therapy.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Dermatology

Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe, Carmen Loquai, Ulrike Nikfarjam, Max Schlaak, Larissa Akcetin, Peter Koelblinger, Magdalena Hoellwerth, Markus Meissner, Guelcin Mengi, Andreas Dominik Braun, Miriam Mengoni, Reinhard Dummer, Joanna Mangana, Mihaela-Anca Sindrilaru, Dan Radmann, Christine Hafner, Johann Freund, Klemens Rappersberger, Felix Weihsengruber, Frank Meiss, Lydia Reinhardt, Friedegund Meier, Barbara Rainer, Erika Richtig, Julia Maria Ressler, Christoph Hoeller, Thomas Eigentler, Teresa Amaral, Wiebke K. Peitsch, Uwe Hillen, Wolfgang Harth, Fabian Ziller, Kerstin Schatton, Thilo Gambichler, Laura Susok, Lara Valeska Maul, Heinz Laubli, Dirk Debus, Carsten Weishaupt, Sevil Boerger, Katharina Sievers, Sebastian Haferkamp, Veronika Zenderowski, Van Anh Nguyen, Marina Wanner, Ralf Gutzmer, Patrick Terheyden, Katharina Kaehler, Steffen Emmert, Alexander Thiem, Michael Sachse, Silke Gercken-Riedel, Kjell Matthias Kaune, Kai-Martin Thoms, Lucie Heinzerling, Markus Vincent Heppt, Sabine Tratzmiller, Wolfram Hoetzenecker, Angela Oellinger, Andreas Steiner, Tobias Peinhaupt, Maurizio Podda, Sabine Schmid, Uwe Wollina, Tilo Biedermann, Christian Posch

Summary: This real-world study examines the clinical outcomes of adjuvant melanoma treatment using PD-1 antibodies and BRAF + MEK inhibitors in specialized skin cancer centers in Germany, Austria, and Switzerland. The results show that patients treated with PD-1 antibodies have a lower 12-month recurrence rate compared to patients treated with BRAF + MEK inhibitors. Additionally, PD-1 antibody treatment is not affected by BRAF mutation status.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Dermatology

Upadacitinib for treatment-resistant Lichen amyloidosis

Farzan Solimani, Amrei Dilling, Franziska C. Ghoreschi, Alexander Nast, Kamran Ghoreschi, Katharina Meier

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Otorhinolaryngology

The Rise of Artificial Intelligence-High Prediction Accuracy in Early Detection of Pigmented Melanoma

Tanja Jutzi, Eva I. Krieghoff-Henning, Titus J. Brinker

Summary: The incidence of malignant melanoma is increasing worldwide and early detection is crucial for effective treatment. Although skin cancer early detection has improved, visual detection of early melanomas remains challenging due to morphological overlaps with nevi. Therefore, there is a high medical need to develop methods for reliable early skin cancer detection.

LARYNGO-RHINO-OTOLOGIE (2023)

Article Biochemistry & Molecular Biology

Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer

Sebastian Foersch, Christina Glasner, Ann-Christin Woerl, Markus Eckstein, Daniel-Christoph Wagner, Stefan Schulz, Franziska Kellers, Aurelie Fernandez, Konstantina Tserea, Michael Kloth, Arndt Hartmann, Achim Heintz, Wilko Weichert, Wilfried Roth, Carol Geppert, Jakob Nikolas Kather, Moritz Jesinghaus

Summary: Researchers developed a multistain deep learning model utilizing artificial intelligence to determine the immunoscore and predict response to neoadjuvant therapy in colorectal cancer patients. The model outperformed other clinical, molecular, and immune cell-based parameters and can serve as a valuable decision-making tool for clinicians.

NATURE MEDICINE (2023)

Article Multidisciplinary Sciences

Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus

Anna M. Sigmund, Markus Winkler, Sophia Engelmayer, Daniela Kugelmann, Desalegn T. Egu, Letyfee S. Steinert, Michael Fuchs, Matthias Hiermair, Mariya Y. Radeva, Franziska C. Bayerbach, Elisabeth Butz, Stefan Kotschi, Christoph Hudemann, Michael Hertl, Sunil Yeruva, Enno Schmidt, Amir S. Yazdi, Kamran Ghoreschi, Franziska Vielmuth, Jens Waschke

Summary: Pemphigus vulgaris is a life-threatening blistering skin disease caused by autoantibodies. Apremilast, a phosphodiesterase 4 inhibitor used in psoriasis, was found to prevent skin blistering in pemphigus vulgaris. It stabilizes keratinocyte adhesion and induces phosphorylation of plakoglobin, leading to the assembly of desmosomal plaques.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Patient-specific identification of genome-wide DNA-methylation differences between intracranial and extracranial melanoma metastases

Theresa Kraft, Konrad Gruetzmann, Matthias Meinhardt, Friedegund Meier, Dana Westphal, Michael Seifert

Summary: Melanomas can metastasize to distant organs, including the brain, posing a clinical challenge. This study reveals that the DNA methylation patterns in intra- and extracranial melanoma metastases are more similar to each other within individual patients than to metastases in the same tissue from other patients. The analysis identifies specific DNA methylation alterations, signaling pathway genes, and gene expression changes that distinguish intra- from extracranial metastases. The findings contribute to a better understanding of the DNA methylation differences in melanoma metastases and may guide future therapeutic approaches.

SCIENTIFIC REPORTS (2023)

Article Medicine, General & Internal

The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy

Georgios Kokolakis, Kamran Ghoreschi

Summary: The understanding of immunopathogenesis of psoriasis has led to the development of targeted therapies, including IL-17 antibodies which have been established for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis. This study presents two patients with psoriasis who lost response to previous treatments, but responded well to bimekizumab, a new antibody that neutralizes both IL-17A and IL-17F. The fast response and lack of side effects suggest the important role of IL-17F and the potential benefit of bimekizumab in non-responders to other anti-IL-17 therapies.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Dermatology

Management of Infections in Psoriatic Patients Treated with Systemic Therapies: A Lesson from the Immunopathogenesis of Psoriasis

Anna Balato, Emanuele Scala, Kilian Eyerich, Nicole Costantino Brembilla, Andrea Chiricozzi, Robert Sabat, Kamran Ghoreschi

Summary: Modern treatments for psoriasis target the immune pathways associated with the disease, but the clinical evidence for increased infection risk is confounded by comorbidities in patients. In an era with a growing infection risk, it is important to stay updated on this risk. This mini-review discusses the immunopathogenesis of psoriasis, the risk of infections linked to the disease and systemic therapy, and provides an overview of infection prevention and management.

DERMATOLOGY PRACTICAL & CONCEPTUAL (2023)

Letter Biochemistry & Molecular Biology

Large language models should be used as scientific reasoning engines, not knowledge databases

Daniel Truhn, Jorge S. Reis-Filho, Jakob Nikolas Kather

NATURE MEDICINE (2023)

Article Cell Biology

Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity

Alexander A. Wurm, Silke Brilloff, Sofia Kolovich, Silvia Schaefer, Elahe Rahimian, Vida Kufrin, Marius Bill, Zunamys I. Carrero, Stephan Drukewitz, Alexander Krueger, Melanie Huether, Sebastian Uhrig, Sandra Oster, Dana Westphal, Friedegund Meier, Katrin Pfutze, Daniel Huebschmann, Peter Horak, Simon Kreutzfeldt, Daniela Richter, Evelin Schroeck, Gustavo Baretton, Christoph Heining, Lino Moehrmann, Stefan Froehling, Claudia R. Ball, Hanno Glimm

Summary: In this study, we investigate the impact of pathway activation on miRNA expression patterns using small RNA sequencing. We discover that miRNAs capable of inhibiting key members of activated pathways are frequently diminished. Based on this observation, we develop an approach to identify druggable target genes in cancer by integrating a low-miRNA-expression signature. We validate our approach in colorectal cancer cells and diverse cancer models and demonstrate its additional value in supporting drug prediction strategies.

CELL REPORTS MEDICINE (2023)

Article Oncology

Deep learning based histological classification of adnex tumors

Philipp Jansen, Jean Le 'Clerc Arrastia, Daniel Otero Baguer, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Michael Emberger, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Klaus Georg Griewank

Summary: This study highlights the enormous potential of artificial intelligence in pathology, showing that it can aid in the identification of rare cutaneous adnexal tumors and potentially become a standard tool in routine diagnostics.

EUROPEAN JOURNAL OF CANCER (2024)

No Data Available